Influence of tumor size in the progression of venous tumor thrombus in renal cell carcinoma: A 7-year single-center experience

被引:4
|
作者
Thangarasu, Mathisekaran [1 ,4 ]
Prakash, J. Sanjay [1 ]
Bafna, Sandeep [1 ]
Aarthy, P. [1 ]
Govindaswamy, Thirumalai Ganesan [1 ]
Venugopal, Balaji [2 ]
Sivaraman, Ananthakrishnan [1 ]
Jain, Nitesh [1 ]
Balakrishnan, Arunkumar [1 ]
Raghavan, Deepak [1 ]
Venkatraman, Murali [1 ]
Chandranathan, M. [3 ]
Paul, Rajesh [1 ]
Selvaraj, Nivash [1 ]
Ramakrishnan, Balasubramaniam [3 ]
Ragavan, Narasimhan [1 ]
机构
[1] Apollo Main Hosp, Dept Genitourinary Surg, Chennai, Tamil Nadu, India
[2] Apollo Main Hosp, Dept Vasc Surg, Chennai, Tamil Nadu, India
[3] Apollo Main Hosp, Dept Biostat, Chennai, Tamil Nadu, India
[4] Apollo Main Hosp, Dept Genitourinary Surg, 21 Greams Lane,Greams Rd, Chennai 600006, Tamil Nadu, India
关键词
Inferior vena cava thrombectomy; nephrectomy; renal cell carcinoma; INFERIOR VENA-CAVA; EXTENSION; CLASSIFICATION; COMPLICATIONS; THROMBECTOMY; SURGERY; CANCER; VEIN;
D O I
10.4103/UA.UA_169_20
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: The objective of the study is to describe the perioperative outcomes, disease-specific, and overall survival status in patients diagnosed with renal cell carcinoma with inferior vena cava (IVC) tumor thrombus. Patients and Methods: We did a retrospective analysis of all patients who underwent radical nephrectomy along with IVC thrombectomy from the year 2013 to 2020. Mayo's classification was used to stratify the level of IVC thrombus. Demographic, perioperative, histopathology data, complications, and survival status were analyzed. Results: Total number of patients included in the study was 39, (Male: Female = 84.6%: 15.4%). Median age of patients was 58 (interquartile range [IQR] 50-63) years. Median size of renal tumor (in cms) was 9.5 (IQR 7.5-12), 8 (IQR 7-11.5), 8.5 (IQR 7-11.75), and 11 (IQR 9.5-11) (P = 0.998) in level 1,2,3, and 4 tumors, respectively. Clear cell variant was seen in 32 patients (82%) with R0 resection in 17 patients. Twelve patients (30.7%) had systemic metastasis on presentation. The overall mean survival time was 66.4 months with 95% confidence interval (CI) (52.4-80.5 months). Mean recurrence-free survival is 76 months with (63-90) CI of 95%. Mean survival in patients who presented with metastasis is 47 months with 95% CI (52.4-80.5). Perioperative mortality rate was 5.12% in this study. Conclusion: The tumor size does not have an influence on the progression of tumor thrombus into IVC. Significant difference in survival was observed between different levels of thrombus with high mortality in level four tumors.
引用
收藏
页码:273 / 278
页数:6
相关论文
共 50 条
  • [31] Renal Tumor Biopsy for Small Renal Masses: A Single-center 13-year Experience
    Richard, Patrick O.
    Jewett, Michael A. S.
    Bhatt, Jaimin R.
    Kachura, John R.
    Evans, Andrew J.
    Zlotta, Alexandre R.
    Hermanns, Thomas
    Juvet, Tristan
    Finelli, Antonio
    EUROPEAN UROLOGY, 2015, 68 (06) : 1007 - 1013
  • [32] Treatment of Nephroblastoma with Venous Thrombus: Single-Center Experience
    Dong, K.
    Weijin, H.
    Xianmin, X.
    Kai, L.
    Min, Y.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S472 - S472
  • [33] The influence of venous tumor thrombus combined with bland thrombus on the surgical treatment and prognosis of renal cell carcinoma patients
    Liu, Zhuo
    Zhang, Li
    Hong, Peng
    Li, Liwei
    Tang, Shiying
    Zhao, Xun
    Zhang, Qiming
    Zhu, Guodong
    Peng, Ran
    Wang, Binshuai
    Chen, Zhigang
    Sun, Zhenghui
    Yang, Feilong
    Wang, Guoliang
    Tian, Xiaojun
    Zhang, Shudong
    Huang, Yi
    Zhang, Hongxian
    Liu, Cheng
    Wang, Shumin
    Ma, Lulin
    CANCER MEDICINE, 2020, 9 (16): : 5860 - 5868
  • [34] Comment to "Prognostic Value of Venous Tumor Thrombus in Renal Cell Carcinoma"
    Fernandez, E.
    ACTAS UROLOGICAS ESPANOLAS, 2012, 36 (01): : 35 - 36
  • [35] Venous tumor thrombus destinations in patients with renal cell carcinoma.
    Nabavizadeh, Reza
    Pessoa, Rodrigo
    Cheville, John
    Lohse, Christine M.
    Costello, Brian Addis
    Lucien, Fabrice
    Thompson, Houston R.
    Boorjian, Stephen A.
    Leibovich, Bradley C.
    Sharma, Vidit
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 381 - 381
  • [36] GROWTH KINETICS OF VENOUS TUMOR THROMBUS IN PATIENTS WITH RENAL CELL CARCINOMA
    Nimrod, Barashi S.
    Daniel, Friedman
    Nicholas, Pickersgill
    Joel, Vetter
    Tara, Suresh
    Joseph, Ippolito E.
    Zachary, Smith L.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S6 - S6
  • [37] Growth kinetics of venous tumor thrombus in patients with renal cell carcinoma
    Barashi, Nimrod S.
    Friedman, Daniel
    Shiang, Alex
    Pickersgill, Nicholas
    Vetter, Joel
    Suresh, Tara
    Ippolito, Joseph E.
    Smith, Zachary L.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (02) : 31e17 - 31e23
  • [38] Natural history of untreated renal cell carcinoma with venous tumor thrombus
    Reese, Adam C.
    Whitson, Jared M.
    Meng, Maxwell V.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (07) : 1305 - 1309
  • [39] Re: Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus
    Matveev, Vsevolod B.
    Volkova, Maria I.
    EUROPEAN UROLOGY, 2017, 72 (06) : 1024 - 1024
  • [40] The Adverse Survival Implications of Bland Thrombus in Renal Cell Carcinoma With Venous Tumor Thrombus
    Hutchinson, Ryan
    Rew, Charles
    Chen, Gong
    Woldu, Solomon
    Krabbe, Laura-Maria
    Meissner, Matthew
    Sheth, Kunj
    Singla, Nirmish
    Shakir, Nabeel
    Master, Viraj A.
    Karam, Jose A.
    Matin, Surena F.
    Borregales, Leonardo D.
    Wood, Christopher
    Masterson, Timothy
    Thompson, R. Houston
    Boorjian, Stephen A.
    Leibovich, Bradley C.
    Abel, E. Jason
    Bagrodia, Aditya
    Margulis, Vitaly
    UROLOGY, 2018, 115 : 119 - 124